The inflammatory milieu in CKD, characterized by elevated MCP-1, exacerbates the progression of carotid atherosclerosis, highlighting the need for targeted therapies that address these inflammatory pathways [37]. The gene discussed is CCL2; the disease is carotid atherosclerosis.